Bazelet Group

Company Overview

Snapshot

Founded in January 2012 by Meir Ariel, Izhak Regev, and Aharon (Ari) Eyal, Bazelet Group operates with 11–50 employees. The company has established itself as a significant player in the medical cannabis sector, including a joint venture in June 2021 to manufacture proprietary products for the Canadian market.

Business overview

Bazelet Group is a medical cannabis company focused on developing innovative enriched-cannabis products. The company's core technology involves processing cannabis and developing proprietary formulations, including terpene-enriched oils and various delivery methods such as cannabis buds, ground flowers, cigarettes, extracts, vaporizer tablets, sustained-release capsules, topicals, and suppositories. Bazelet Group serves the medical cannabis market, providing products and services to patients, and operates within the Health Tech & Life Sciences sector, specifically in Pharma & Medical Biotechnology, Medical Cannabis, and Drug Delivery.

Strategic signal

In June 2021, Bazelet Group entered into a joint venture with Ayurcann Holdings Corp. to manufacture proprietary medical cannabis products for the Canadian market. This partnership signifies Bazelet's strategic expansion into international markets and validates its product development capabilities, signaling potential for significant growth and broader market reach for investors.

Company Intelligence Q&A

What is Bazelet Group's primary focus?

Bazelet Group is a medical cannabis company that focuses on scientific incubation and the development of innovative enriched-cannabis products, serving patients with various medical needs.

What types of products does Bazelet Group offer?

Bazelet Group offers a range of medical cannabis products, including cannabis buds in sealed, barcoded packages; flowers ground in a proprietary method; cannabis cigarettes; cannabis extracts; vaporizer tablets; sustained-release capsules; topicals; and suppositories.

When did Bazelet Group launch its terpene-enriched medical cannabis oils?

In January 2021, Bazelet launched multiple lines of proprietary terpene-enriched medical cannabis oils designed for specific medical needs such as women's health, pain treatment, improved sleep, and the needs of the elderly population.

Has Bazelet Group expanded its operations internationally?

In June 2021, Bazelet Group, through its subsidiaries Bazelet Nehushtan Ltd. and Bazelet Development and Technologies Ltd., formed a joint venture with Ayurcann Holdings Corp. to manufacture proprietary products for the Canadian market.

What services does Bazelet Group provide to its patients?

Bazelet Group provides secure delivery of products to homes monthly, educates newly licensed users, offers guidance and strain-selection advice to clients, and operates a call center to support its 9,000 patients per month.